Eczema Drugs Could Counter Ovarian Cancer’s IL-4-Based Immunotherapy Resistance
Study findings suggest the potential to repurpose a drug that is FDA-approved for treating asthma and eczema, to enhance immunotherapy for ovarian cancer.
Study findings suggest the potential to repurpose a drug that is FDA-approved for treating asthma and eczema, to enhance immunotherapy for ovarian cancer.
Amyloid-related imaging abnormalities (ARIA), side effects of anti-amyloid drugs seen in magnetic resonance imaging of the brain, are a major safety concern in patients with…
A generative AI platform is developed for de novo antibiotic design, yielding lead compounds with selective antibacterial activity, distinct mechanisms of action, and in vivo…
Unlike people, these nest-building insects pull harder in teams
BUB1 exits nucleus postirradiation to clear dsRNA via PABPC1, which boosts MDA5-IFN signaling and CD8 T cell–driven radiosensitivity.
The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.
Data from a new study elucidates the role of a transcriptional enhancer dubbed HAR123 in neural cell development and cognitive flexibility.
Absci and Almirall have expanded their 21-month-old AI-based collaboration to develop and commercialize therapeutics for chronic skin diseases.
An Illinois judge on Wednesday declined Texas Attorney General Ken Paxton’s (R) request to hold Texas Democrats who fled there in contempt. Paxton reached across…
The Dubai Health Authority’s Dr. Mohammad Al Redha says Dubai is building a foundation for AI tools to advance care delivery by making some clinical…
Study marks the first time scientists have observed this kind of “manipulative” behavior in spiders